| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |